Search bioRxiv⌕ Search

Biology subjects

Rani, S.

Publications and source records attributed to Rani, S..

3 recordsLinked to original sources

A conformationally heterogeneous bending pivot enables bent-to-straight transition in the central helix of mycobacterial FtsZ

Conformational changes in the central helix at the inter-domain cleft of bacterial treadmilling motor protein FtsZ are coupled to polymerization. Central helix of mycobacterial FtsZ interconverts between a bent and a straight form, with an unknown mechanism. We probed the mechanism of this conformational switching in the central helix of mycobacterial FtsZ using multi-temperature synchrotron crystallography at 20 {o}C, 30 {o}C, 37 {o}C and -173 {o}C temperatures. A comparison of the resultant crystal structures of FtsZ revealed altered conformations at the bending pivot of the bent central helix inside the inter-domain cleft. Further, ensemble modeling of FtsZ structure shows that this bending pivot is labile at near-physiological temperatures. Conformational fluctuations in this pivot region resulted in breakage of regular alpha helical hydrogen bonds that likely made the central helix easily bendable. These fluctuations are largely arrested in the straightened form of the central helix in comparison to the bent form. To summarize, multi-temperature crystallography combined with ensemble modeling suggest that conformational heterogeneity and associated perturbations of helix-forming interactions in the bending pivot can trigger bent-to-straight conformational transition in the central helix of mycobacterial FtsZ. This work demonstrates the effectiveness of multi-temperature crystallography in delineating the mechanisms of conformational changes in protein machines.

biophysics↗

Inhibition of BCR::ABL1 tyrosine kinase activity Aids in the Generation of Stable Chronic Myeloid Leukemia Induced Pluripotent Stem Cells

Induced pluripotent stem cells (iPSCs) generated from patients with chronic myeloid leukemia (CML) have the potential for disease modeling to study disease pathogenesis and screening therapeutic interventions. In this study, we aimed to generate iPSCs from CD34+ hematopoietic progenitors of CML patients with varying responses to tyrosine kinase inhibitor (TKI) therapy. The generated CML-CD34-iPSC colonies displayed atypical "dome-shaped" morphology and underwent spontaneous differentiation in a few days. However, supplementation with imatinib (IM), the most widely used TKI to treat CML patients, in the culture medium improved the stability and maintenance of all isolated CML-CD34-iPSC colonies, allowing them to be maintained for more than 20 passages without significant differentiation. In contrast to previous studies, our results indicate that suppressing the BCR::ABL1 oncogenic pathway is essential for efficiently generating stable CML-iPSC colonies. Furthermore, we successfully differentiated these iPSCs to CD34+ hematopoietic progenitors both in the presence and absence of IM. This robust protocol for generating CML-iPSCs provides a valuable resource for disease modelling. The generated iPSCs will be a valuable tool for investigating CML pathophysiology, drug resistance mechanisms, and drug screening to identify novel and effective therapies for this disease.

cancer biology↗

Evaluation of anticancer and anti-mitotic properties of quinazoline and quinazolino-benzothiadiazine derivatives

Cancer is one of the major health and social-economic problems despite considerable progress in its early diagnosis and treatment. Owing to the emergence and increase of multi drug resistance to various conventional drugs, and the continuing importance on health-care expenditure, many researchers have focused to develop novel and effective anticancer compounds. In the present study, a series of in-house synthesized quinazoline and quinazolino-benzothiadiazine derivatives were investigated for their anticancer efficacy against a panel of five cancer (DU145, MCF7, HepG2, SKOV3 and MDA-MB-231) and one normal (MRC5) cell lines. Among all the tested compounds, fifteen of them exhibited promising growth-inhibitory effect (0.15 - 5.0 M) and induced cell cycle arrest in G2/M phase. In addition, the selected compounds inhibited the microtubule assembly; altered mitochondrial membrane potential and enhanced the levels of caspase-9 in MCF-7 cells. Furthermore, the active compound with combination of drugs showed synergistic effect at lower concentrations and the drug uptake was mediated through clathrin mediated endocytic pathway. Our results indicated that quinazoline and quinazolino-benzothiadiazine conjugates could serve as potential leads in the development of personalized cancer therapeutics.\n\nSummaryThe present study describes the exploration of small molecules based on heterocyclic scaffolds for tubulin target based development of anticancer agents.

cancer biology↗